Meihua Luo
- Co-authors
- Mark R. KelleyRichard F. BorchWuguo DengGang LiJianjun ChenWendan YuKun ZouWei Guo
- Topics
- Cancer-related Molecular Pathways (4 papers)Venous Thromboembolism Diagnosis and Management (4 papers)DNA Repair Mechanisms (3 papers)
- Partner nations
- ChinaUnited StatesItaly
In The Last Decade
Meihua Luo
26 papers receiving 523 citations
Peers
Comparison fields: 5 of 74
- Molecular Biology 334
- Oncology 132
- Cancer Research 96
- Surgery 59
- Organic Chemistry 58
Countries citing papers authored by Meihua Luo
This map shows the geographic impact of Meihua Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meihua Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meihua Luo more than expected).
Fields of papers citing papers by Meihua Luo
This network shows the impact of papers produced by Meihua Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meihua Luo. The network helps show where Meihua Luo may publish in the future.
Co-authorship network of co-authors of Meihua Luo
This figure shows the co-authorship network connecting the top 25 collaborators of Meihua Luo. A scholar is included among the top collaborators of Meihua Luo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Meihua Luo. Meihua Luo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 1 | |
| 4 | 4 | |
| 5 | 6 | |
| 6 | 2 | |
| 7 | 7 | |
| 8 | 32 | |
| 9 | 43 | |
| 10 | 26 | |
| 11 | 23 | |
| 12 | 70 | |
| 13 | 12 | |
| 14 | 10 | |
| 15 | 41 | |
| 16 | A proteomics-based investigation on the anticancer activity of alisertib, an Aurora kinase A inhibitor, in hepatocellular carcinoma Hep3B cells. | 5 |
| 17 | [Clinical significance of monitoring coagulation- and fibrinolysis-related indexes during catheter-directed thrombolysis for acute lower-extremity deep venous thrombosis]. | 1 |
| 18 | 2 | |
| 19 | 36 | |
| 20 | 5 |
About Meihua Luo
Meihua Luo is a scholar working on Internal Medicine, Emergency Medical Services and Cancer Research, having authored 27 papers that have together received 527 indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (4 papers), Venous Thromboembolism Diagnosis and Management (4 papers) and DNA Repair Mechanisms (3 papers). The work is most often cited by research in Internal Medicine (44 citations), Cancer Research (96 citations) and Molecular Biology (334 citations). Meihua Luo has collaborated with scholars based in China, United States and Italy. Frequent co-authors include Mark R. Kelley, Richard F. Borch, Wuguo Deng, Gang Li, Jianjun Chen, Wendan Yu, Kun Zou, Wei Guo, Lijuan Zou and Fufu Zheng. Their work appears in journals such as Journal of Medicinal Chemistry, Journal of Investigative Dermatology and Life Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.